PharmaMar is up 7.75% this Friday after meeting, at the end of last day, that it will become part of the Ibex to replace Ence from September 21.
"The entrance of PharmaMar not surprising (it was expected to replace MásMóvil as of October 14) and Ence I was already among the candidates to leave at the last meeting in June. The idea continues to be that MásMóvil comes out after the takeover bid and the index would remain with 34 values until October 7, when an extraordinary meeting would propose his replacement", explain the experts from Banco Sabadell.
Income 4 analysts point out that we will soon have another change after the takeover bid for MásMóvil be successful, which will leave a new hole in the selective. "The best positioned value to occupy its place would be Ebro Foods", they indicate.
For José María Rodríguez, an expert at Bolsamanía, the entry of PharmaMar confirms the idea that the Ibex Technical Advisory Committee "wants to give the selective one a spin". "Maybe you want to give the Ibex a little facelift. That they stop being all banks, Iberdrola, Telefónica and Inditex"says Rodríguez.
The entry of PharmaMar joins that of Almirall, another pharmaceutical company. Together with Grifols, the sector already has a strong presence in the Spanish index. "Biotechnology and pharmaceuticals are in fashion because of the virus," says José María Rodríguez.
. (tagsToTranslate) PharmaMar (t) rises (t) after (t) income (t) Ibex (t) while (t) Ebro (t) profiles (t) as (t) next (t) Category: All (t) Category: Company News (t) Category: Europe Report (t) Category: International News (t) Category: Pulses (t) Category: Pulses Europe (t) mostread_ultimas (t) mostread_fundsnews (t) mostread_empresas (t) mostread_internacional